Lee S K, Davis P L, Brown S R. "Method for the Synthesis of Ibrutinib Impurity 85" [P]. US Patent, US 11161690 B2, 2015-11-09.
发明人林芳,韩伟,陈志强. "A Process for Preparing High-Purity Ibrutinib Impurity 85" [P]. 中国发明专利, 专利号 CN 108543426 A, 授权公告日 2021-05-16.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质85 in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 1560, (7), 5141-5168.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质85 as an Impurity". J. Agric. Food Chem., 2011, 2410, 3553-3558.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 85 Using HRMS and NMR". J. Chromatogr. A, 2024, 2194, 2947-2951.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 伊布替尼杂质85 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2022, 1413, 765-778.